[Psychopharmalogical study of a central alpha-sympathomimetic agent, xylazine analgesic and tranquillizer in veterinary medicine].
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000661:Amphetamine / Q000494:pharmacology; D000700:Analgesics / Q000494:pharmacology; D000814:Aniline Compounds / Q000494:pharmacology; D000820:Animal Diseases / Q000188:drug therapy; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D002490:Central Nervous System / Q000187:drug effects*; D004336:Drug Antagonism; D009043:Motor Activity / Q000187:drug effects; D011600:Psychopharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology*; D013843:Thiazines / Q000494:pharmacology; D014149:Tranquilizing Agents / Q000494:pharmacology; D014730:Veterinary Medicine; D014992:Xylenes / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D000700:Analgesics; D000814:Aniline Compounds; D013566:Sympathomimetics; D013843:Thiazines; D014149:Tranquilizing Agents; D014992:Xylenes; D012110:Reserpine; D000661:Amphetamine; D001058:Apomorphine
Profil psychopharmacologique d'un alpha-sympathomimétique central, la xylazine, analgésique et tranquillisant en médecine vétérinaire